Cargando…

Smoking signature is superior to programmed death-ligand 1 expression in predicting pathological response to neoadjuvant immunotherapy in lung cancer patients

BACKGROUND: There is a paucity of biomarkers that can predict the degree of pathological response [e.g., pathological complete response (pCR) or major response (pMR)] to immunotherapy. Neoadjuvant immunotherapy provides an ideal setting for exploring responsive biomarkers because the pathological re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Haitang, Ma, Wenyan, Sun, Beibei, Fan, Liwen, Xu, Ke, Hall, Sean R. R., Al-Hurani, Mohammad Faisal, Schmid, Ralph A., Peng, Ren-Wang, Hida, Toyoaki, Wang, Zhexin, Yao, Feng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8512473/ https://www.ncbi.nlm.nih.gov/pubmed/34733630 http://dx.doi.org/10.21037/tlcr-21-734

Ejemplares similares

Neoadjuvant immunotherapy facilitates resection of surgically-challenging lung squamous cell cancer
por: Xu, Ke, et al.
Publicado: (2021)

Multi-scale characterization of tumor-draining lymph nodes in resectable lung cancer treated with neoadjuvant immune checkpoint inhibitors
por: Yang, Haitang, et al.
Publicado: (2022)

Implementation of smoking signature as an improved biomarker predicting the response to immunotherapy
por: Yang, Haitang, et al.
Publicado: (2022)

Multi-scale integrative analyses identify THBS2(+) cancer-associated fibroblasts as a key orchestrator promoting aggressiveness in early-stage lung adenocarcinoma
por: Yang, Haitang, et al.
Publicado: (2022)

The improved success rate and reduced complications of a novel localization device vs. hookwire for thoracoscopic resection of small pulmonary nodules: a single-center, open-label, randomized clinical trial
por: Fan, Liwen, et al.
Publicado: (2022)

Biomarker-guided targeted and immunotherapies in malignant pleural mesothelioma
por: Yang, Haitang, et al.
Publicado: (2020)

Advances in immunotherapy for stage III non-small cell lung cancer: moving immune checkpoint inhibitors to the front lines concurrently with chemoradiotherapy?
por: Hida, Toyoaki, et al.
Publicado: (2020)

Pharmaco-transcriptomic correlation analysis reveals novel responsive signatures to HDAC inhibitors and identifies Dasatinib as a synergistic interactor in small-cell lung cancer
por: Yang, Haitang, et al.
Publicado: (2021)

NF2 and Canonical Hippo-YAP Pathway Define Distinct Tumor Subsets Characterized by Different Immune Deficiency and Treatment Implications in Human Pleural Mesothelioma
por: Yang, Haitang, et al.
Publicado: (2021)

Targeting histone deacetylase enhances the therapeutic effect of Erastin-induced ferroptosis in EGFR-activating mutant lung adenocarcinoma
por: Zhang, Tuo, et al.
Publicado: (2021)

Expert consensus on neoadjuvant immunotherapy for non-small cell lung cancer
por: Liang, Wenhua, et al.
Publicado: (2020)

Comment on “Heterogeneity in PD-L1 expression in malignant peritoneal mesothelioma with systemic or intraperitoneal chemotherapy”
por: Yang, Haitang, et al.
Publicado: (2020)

Neoadjuvant Immunotherapy for Hepatocellular Carcinoma
por: Marron, Thomas U, et al.
Publicado: (2022)

Indocyanine green fluorescence-navigated thoracoscopy versus traditional inflation-deflation approach in precise uniportal segmentectomy: a short-term outcome comparative study
por: Fan, Wenbin, et al.
Publicado: (2022)

Smoking signature as a biomarker for immunotherapy
por: Li, Mengqian, et al.
Publicado: (2022)

Neoadjuvant immunotherapy of locoregionally advanced solid tumors
por: Tarhini, Ahmad A, et al.
Publicado: (2022)

Surgical Resection of Primary Tumors Provides Survival Benefits for Lung Cancer Patients With Unexpected Pleural Dissemination
por: Fan, Liwen, et al.
Publicado: (2021)

Nivolumab for the treatment of Japanese patients with advanced metastatic non-small cell lung cancer: a review of clinical trial evidence for efficacy and safety
por: Hida, Toyoaki
Publicado: (2018)

Anaplastic lymphoma kinase inhibitor development: enhanced delivery to the central nervous system
por: Hida, Toyoaki
Publicado: (2023)

Pseudoprogression with Neoadjuvant Immunotherapy for Cutaneous Melanoma
por: Garcia, Diogo, et al.
Publicado: (2021)

Therapeutic Landscape of Malignant Pleural Mesothelioma: Collateral Vulnerabilities and Evolutionary Dependencies in the Spotlight
por: Xu, Duo, et al.
Publicado: (2020)

A Rare Case of Spontaneous Pneumomediastinum in a Female After Shouting: A Literature Review
por: Al-Hurani, Mohammad
Publicado: (2022)

A narrative review of primary research endpoints of neoadjuvant therapy for lung cancer: past, present and future
por: Ren, Sijia, et al.
Publicado: (2021)

New Horizons in KRAS-Mutant Lung Cancer: Dawn After Darkness
por: Yang, Haitang, et al.
Publicado: (2019)

Immunotherapy for Ovarian Cancer: Adjuvant, Combination, and Neoadjuvant
por: Yang, Chang, et al.
Publicado: (2020)

Review and perspective on adjuvant and neoadjuvant immunotherapies in NSCLC
por: Yi, Chengxiang, et al.
Publicado: (2019)

Neoadjuvant Immunotherapy for Muscle-Invasive Bladder Cancer
por: Peyrottes, Arthur, et al.
Publicado: (2021)

Lung Cancer Surgery after Neoadjuvant Immunotherapy
por: Stefani, Dirk, et al.
Publicado: (2021)

Exploring the Evolving Scope of Neoadjuvant Immunotherapy in NSCLC
por: Roller, John F., et al.
Publicado: (2022)

Anaesthesia after neoadjuvant chemotherapy, immunotherapy or radiotherapy
por: Groenewold, M.D., et al.
Publicado: (2022)

Neoadjuvant immunotherapy in primary and metastatic colorectal cancer
por: Kanani, A, et al.
Publicado: (2021)

Meta-analysis of neoadjuvant immunotherapy for non-metastatic colorectal cancer
por: Zhou, Long, et al.
Publicado: (2023)

Zaina Jamal Sudqi Hurani
por: Hurani, Zaina Jamal Sudqi
Publicado: (2023)

Addition of atezolizumab to nab-paclitaxel plus carboplatin is a new standard option for the first-line treatment for non-squamous non-small cell lung cancer
por: Yamaguchi, Teppei, et al.
Publicado: (2019)

Electrocautery smoke exposure and efficacy of smoke evacuation systems in minimally invasive and open surgery: a prospective randomized study
por: Kocher, Gregor J., et al.
Publicado: (2022)

Case report: Complete resection of invasive thymoma invading the superior vena cava and right atrium under cardiopulmonary bypass support
por: Zhang, Xiangxin, et al.
Publicado: (2022)

An Immune-Related Gene Signature for Predicting Neoadjuvant Chemoradiotherapy Efficacy in Rectal Carcinoma
por: Qian, Liwen, et al.
Publicado: (2022)

Neoadjuvant anti-PD-1 immunotherapy for recurrent glioblastoma
por: Mitchell, Dana, et al.
Publicado: (2019)

Neoadjuvant immunotherapy in breast cancer: a paradigm shift?
por: Fountzila, Elena, et al.
Publicado: (2020)

Neoadjuvant checkpoint inhibitor immunotherapy for resectable mucosal melanoma
por: Ho, Joel, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_g9c3ebm1i602e2k6bic90d6epp